148 related articles for article (PubMed ID: 36114089)
1. The spike hypothesis in vaccine-induced adverse effects: questions and answers.
Cosentino M; Marino F
Trends Mol Med; 2022 Oct; 28(10):797-799. PubMed ID: 36114089
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis.
Trougakos IP; Terpos E; Alexopoulos H; Politou M; Paraskevis D; Scorilas A; Kastritis E; Andreakos E; Dimopoulos MA
Trends Mol Med; 2022 Jul; 28(7):542-554. PubMed ID: 35537987
[TBL] [Abstract][Full Text] [Related]
3. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
Maeda M; Isawa T; Tada N
Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
[No Abstract] [Full Text] [Related]
4. Adverse events following COVID-19 vaccination: A systematic review and meta-analysis.
Kouhpayeh H; Ansari H
Int Immunopharmacol; 2022 Aug; 109():108906. PubMed ID: 35671640
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine associated transverse myelitis-Evusheld as an option when vaccination is not recommended due to severe adverse events.
Fitzsimmons WE
Hum Vaccin Immunother; 2022 Nov; 18(5):2068338. PubMed ID: 35511579
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE-An Observational Study.
Ganesan S; Al Ketbi LMB; Al Kaabi N; Al Mansoori M; Al Maskari NN; Al Shamsi MS; Alderei AS; El Eissaee HN; Al Ketbi RM; Al Shamsi NS; Saleh KM; Al Blooshi AF; Cantarutti FM; Warren K; Ahamed F; Zaher W
Front Public Health; 2022; 10():876336. PubMed ID: 35602146
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated.
Lazarinis N; Bossios A; Gülen T
J Allergy Clin Immunol Pract; 2022 May; 10(5):1377-1379. PubMed ID: 35123098
[No Abstract] [Full Text] [Related]
9. COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknowns.
Trougakos IP; Terpos E; Alexopoulos H; Politou M; Paraskevis D; Scorilas A; Kastritis E; Andreakos E; Dimopoulos MA
Trends Mol Med; 2022 Oct; 28(10):800-802. PubMed ID: 36114090
[No Abstract] [Full Text] [Related]
10. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
Pitlick MM; Joshi AY; Gonzalez-Estrada A; Chiarella SE
Allergy Asthma Proc; 2022 Jan; 43(1):40-43. PubMed ID: 34983709
[No Abstract] [Full Text] [Related]
11. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
[TBL] [Abstract][Full Text] [Related]
12. A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins.
Metin Z; Celepli P
Int J Dermatol; 2022 May; 61(5):639-641. PubMed ID: 35073411
[No Abstract] [Full Text] [Related]
13. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review.
Lv J; Wu H; Xu J; Liu J
Infect Dis Poverty; 2022 May; 11(1):53. PubMed ID: 35562753
[TBL] [Abstract][Full Text] [Related]
15. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
17. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.
Hause AM; Zhang B; Yue X; Marquez P; Myers TR; Parker C; Gee J; Su J; Shimabukuro TT; Shay DK
JAMA Netw Open; 2022 Jul; 5(7):e2222241. PubMed ID: 35838667
[TBL] [Abstract][Full Text] [Related]
18. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe.
Rosenblum HG; Gee J; Liu R; Marquez PL; Zhang B; Strid P; Abara WE; McNeil MM; Myers TR; Hause AM; Su JR; Markowitz LE; Shimabukuro TT; Shay DK
Lancet Infect Dis; 2022 Jun; 22(6):802-812. PubMed ID: 35271805
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Yang S; Li Y; Dai L; Wang J; He P; Li C; Fang X; Wang C; Zhao X; Huang E; Wu C; Zhong Z; Wang F; Duan X; Tian S; Wu L; Liu Y; Luo Y; Chen Z; Li F; Li J; Yu X; Ren H; Liu L; Meng S; Yan J; Hu Z; Gao L; Gao GF
Lancet Infect Dis; 2021 Aug; 21(8):1107-1119. PubMed ID: 33773111
[TBL] [Abstract][Full Text] [Related]
20. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK
Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
